Drug Profile
VAX 102
Alternative Names: Flagellin.HuM2e; M2e universal influenza vaccine - VaxInnate; M2e-Flagellin; STF2.4xM2e; VAX102Latest Information Update: 30 Jun 2020
Price :
$50
*
At a glance
- Originator VaxInnate
- Class Antivirals; Influenza A vaccines; Recombinant fusion proteins
- Mechanism of Action Immunostimulants; Toll-like receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Influenza A virus infections
Most Recent Events
- 18 Jun 2020 CJ HealthCare is now called HK inno.N
- 22 Sep 2015 No recent reports on development identified - Phase-I for Influenza-A virus infections (Combination therapy, Prevention, In volunteers) in USA (IM)
- 22 Sep 2015 No recent reports on development identified - Phase-I/II for Influenza-A virus infections (Prevention, In volunteers) in USA (IM & SC)